Researchers discover proteins in the IL-6 signaling pathway may be leveraged as novel biomarkers of multiple sclerosis (MS) to gauge disease activity and as a target for new therapies.
Researchers have presented two studies introducing new indicator molecules that can visualize the activation of T cells. Their findings provide new insight into the role of these cells in the autoimmune disease multiple sclerosis.
Researchers implant human stems cells into the spinal cords of mice crippled by an autoimmune disease similar to MS, helping the mice to regain the ability to move and walk.
A new study reports researchers have discovered a way to enhance the effects of immunotherapy to treat glioblastoma.
New findings could help point the way to new targets for developing treatments for multiple sclerosis.
Researchers explore the interplay between the brain and immune system to find new potential targets for treating Alzheimer's disease.
Researchers have developed a promising new combination therapy for the treatment of glioblastoma brain cancer.
A new study reports a small group of people with relapsing remitting multiple sclerosis experienced improvement to their symptoms during the fall and winter seasons.
Researchers report disruption of the BBB can trigger a cascade of events that result in brain damage and autoimmunity characteristic of MS.
Researchers have identified a key protein involved in the inflammatory immune response that drives the progression of multiple sclerosis.